CLINICAL_TRIALS
trial_result
· 2021-09-24
Clinical Trial Update: Rhopressa for Corneal Edema Associated With Fuchs Dystrophy [Phase 2, Phase 3]
Summary
Phase 2/Phase 3 trial results for Rhopressa in corneal edema due to Fuchs endothelial corneal dystrophy have been completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Price Vision Group | Conditions: Fuchs Endothelial Dystrophy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2021-09-24